• Focused on improving patient care

  • Quality matters
    Plasmasicherheit

  • Understanding the fragility and value of life

  • Developing future solutions for unmet patient needs


News

08.03.2016
Octapharma Group publishes 2015 annual results reporting revenue of €1.5 billion and operating income of €351 million

Lachen, Switzerland, March 8th, 2016: the Octapharma Group publishes its 2015 annual results reporti...

20.01.2016
Octapharma Australia provides octaplasLG® for free to a young patient with C1q deficiency

Lachen, Switzerland, January 20th, 2016: Since 2011, Octapharma Australia has provided octaplas...